Allspring Global Investments Holdings, LLC Tg Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 17,118 shares of TGTX stock, worth $514,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,118
Previous 18,313
6.53%
Holding current value
$514,395
Previous $325,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TGTX
# of Institutions
337Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$462 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$342 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$273 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$108 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$96.3 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.37B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...